邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

PTEN基因与消化系统器官纤维化

张晓云,  郝建宇

downloadPDF
文章导航 > 协和医学杂志  > 2017 >  8(4-5): 300-304
张晓云, 郝建宇. PTEN基因与消化系统器官纤维化[J]. 协和医学杂志, 2017, 8(4-5): 300-304. doi: 10.3969/j.issn.1674-9081.2017.05.020
引用本文: 张晓云, 郝建宇. PTEN基因与消化系统器官纤维化[J]. 协和医学杂志, 2017, 8(4-5): 300-304. doi: 10.3969/j.issn.1674-9081.2017.05.020
shu
Xiao-yun ZHANG, Jian-yu HAO. PTEN and Digestive Organ Fibrosis[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(4-5): 300-304. doi: 10.3969/j.issn.1674-9081.2017.05.020
Citation: Xiao-yun ZHANG, Jian-yu HAO. PTEN and Digestive Organ Fibrosis[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(4-5): 300-304. doi: 10.3969/j.issn.1674-9081.2017.05.020
shu

PTEN基因与消化系统器官纤维化

doi: 10.3969/j.issn.1674-9081.2017.05.020

  • 首都医科大学附属北京朝阳医院消化内科, 北京 100020

基金项目: 

国家自然科学基金面上项目 81470888

详细信息
    通讯作者:

    郝建宇  电话:010-85231714,E-mail: haojianyu@medmail.com.cn

  • 中图分类号: R57;Q71

PTEN and Digestive Organ Fibrosis

  • Department of Gastroenterology, Beijing Chaoyang Hospital Affiliated to Capital Medical University, Beijing 100020

More Information

    摘要
  • 摘要: PTEN基因是目前发现的重要抑癌基因之一, 其蛋白产物具有独特的蛋白磷酸酶及脂质磷酸酶双重活性。PTEN蛋白分布广泛、生物学功能复杂、调节方式多样, 可通过多种信号转导途径对细胞的形态、增殖、分化、黏附、迁移等发挥调节作用。随着对PTEN基因的深入研究, 揭示该基因与多种消化器官纤维化过程密切相关, 并可能成为逆转及治疗纤维化的潜在靶点。
    Abstract: PTEN gene is one of the most important tumor suppressor gene, which acts through a unique protein phosphatase and lipid phosphates activity. PTEN protein has a wide distribution, complex biological function, and a variety of regulation modes, which can regulate the cell morphology, proliferation, differentiation, adhesion and migration through a variety of signaling pathways. With the further study of PTEN, it is found that the gene is closely related to the digestive process of many kinds of digestive organs, and may be a potential target for the reversing and treatment of fibrosis.
    • HTML全文
    • 参考文献(42)
  • [1] Li J, Yen C, Liaw D, et al. PTEN. a putative protein tyrosine phesphatasc gene mutated in human brain, breastand prostate cancer[J]. Science, 1997, 275:1943-1947. doi:  10.1126/science.275.5308.1943
    [2] Steck PA, Pershouse MA, Jasser SA, et al.Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers[J]. Nat Genet, 1997, 15:356-362. doi:  10.1038/ng0497-356
    [3] Li DM, Sun H.TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta[J]. Cancer Res, 1997, 57:2124-2129. https://cancerres.aacrjournals.org/content/canres/57/11/2124.full.pdf
    [4] Milella M, Falcone I, Conciatori F, et al. PTEN:multiple functions in human malignant tumors[J]. Front Oncol, 2015, 5:24. https://www.ncbi.nlm.nih.gov/pubmed/25763354
    [5] Lee JO, Yang H, Georgescu MM, et al. Crystal structure of the PTEN tumour suppressor:implications for its phosphoinositide phosphatase activity and membrane association[J]. Cell, 1999, 99:323-334. doi:  10.1016/S0092-8674(00)81663-3
    [6] Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate[J]. J Biol Chem, 1998, 273:13375-13378. doi:  10.1074/jbc.273.22.13375
    [7] Stambolic V, Suzuki A, de la Pompa JL, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN[J]. Cell, 1998, 95:29-39. doi:  10.1016/S0092-8674(00)81780-8
    [8] Conidi A, Cazzola S, Beets K, et al. Few Smad proteins and many Smad-interacting proteins yield multiple functions and action modes in TGFβ/BMP signaling in vivo[J]. Cytokine Growth Factor Rev, 2011, 22:287-300. doi:  10.1016/j.cytogfr.2011.11.006
    [9] Wang S, Cheng Z, Yang X, et al. Effect of wild type PTEN gene on proliferation and invasion of multiple myeloma[J]. Int J Hematol, 2010, 92:83-94. doi:  10.1007/s12185-010-0604-y
    [10] Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor[J]. Nat Rev Mol Cell Biol, 2012, 13:283-296. doi:  10.1038/nrm3330
    [11] White ES, Thannickal VJ, Carskadon SL, et al. Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts:a role for phosphatase and tensin homologue deleted on chromosome 10[J].Am J Respir Crit Care Med, 2003, 168:436-442. doi:  10.1164/rccm.200301-041OC
    [12] Parapuram SK, Shi-wen X, Elliott C, et al. Loss of PTEN expression by dermalfibroblasts causesskin fibrosis[J]. J Invest Dermatol, 2011, 131:1996-2003. doi:  10.1038/jid.2011.156
    [13] Zheng L, Chen X, Guo J, et al. Differential expression of PTEN in hepatic tissue and hepatic stellate cells during rat liver fibrosis and its reversal[J]. Int J Mol Med, 2012, 30:1424-1430. doi:  10.3892/ijmm.2012.1151
    [14] Im E, Jung J, Pothoulakis C, et al. Disruption of Pten speeds onset and increases severity of spontaneous colitis in Il10(-/-) mice[J]. Gastroenterology, 2014, 147:667-669. doi:  10.1053/j.gastro.2014.05.034
    [15] Wang L, Zhang N, Wang Z, et al. Pseudogene PTENP1 Functions as a Competing Endogenous RNA (ceRNA) to Regulate PTEN Expression by Sponging miR-499-5p[J]. Biochemistry (Mosc), 2016, 81:739-747. doi:  10.1134/S0006297916070105
    [16] Vazquez F, Ramaswamy S, Nakamura N, et al. Phosphory-lation of the PTEN tail regulates protein stability and function[J].Mol Cell Biol, 2000, 20:5010-5018. doi:  10.1128/MCB.20.14.5010-5018.2000
    [17] Putz U, Mah S, Goh CP, et al. PTEN secretion in exosomes[J]. Methods, 2015, 77-78:157-163. doi:  10.1016/j.ymeth.2014.12.016
    [18] Bian EB, Huang C, Ma TT, et al. DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats[J]. Toxicol Appl Pharmacol, 2012, 264:13-22. doi:  10.1016/j.taap.2012.06.022
    [19] Lorenzen JM, Schauerte C, Hübner A, et al. Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis[J]. Eur Heart J, 2015, 36:2184-2196. doi:  10.1093/eurheartj/ehv109
    [20] Zhong C, Wang K, Liu Y, et al. miR-19b controls cardiac fibroblast proliferation and migration[J]. J Cell Mol Med, 2016, 20:1191-1197. doi:  10.1111/jcmm.12858
    [21] Kuninty PR, Bojmar L, Tjomsland V, et al. MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor[J]. Oncotarget, 2016, 7:16396-16408. doi:  10.18632/oncotarget.7651
    [22] Manning BD, CantleyLC. AKT/PKB signaling:navigating downstream[J]. Cell, 2007, 129, 1261-1274. doi:  10.1016/j.cell.2007.06.009
    [23] Schwock J, Dhani N, Hedley DW. Targeting focal adhesion kinase signaling in tumor growth and metastasis[J]. Expert Opin Ther Targets, 2010, 14:77-94. doi:  10.1517/14728220903460340
    [24] Xia H, Diebold D, Nho R, et al. Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis[J]. J Exp Med 2008, 205:1659-1672. doi:  10.1084/jem.20080001
    [25] Samarakoon R, Helo S, Dobberfuhl AD, et al. Loss of tumour suppressor PTEN expression in renal injury initiates SMAD3- and p53-dependent fibrotic responses[J]. J Pathol, 2015, 236:421-432. doi:  10.1002/path.4538
    [26] Gao Y, Chu M, Hong J, et al. Hypoxia induces cardiac fibroblast proliferation and phenotypic switch:a role for caveolae and caveolin-1/PTEN mediated pathway[J]. J Thorac Dis, 2014, 6:1458-1468. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215158/
    [27] Danussi C, Petrucco A, Wassermann B, et al. EMILIN1-α4/α9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation[J]. J Cell Biol, 2011, 195:131-145. doi:  10.1083/jcb.201008013
    [28] Eng FJ, Friedman SL, Fibrogenesis I. New insights into hepatic stellate cell activation:the simple becomes complex[J]. Am J Physiol Gastrointest Liver Physiol, 2000, 279:G7-G11. doi:  10.1152/ajpgi.2000.279.1.G7
    [29] Reif S, Lang A, Lindquist JN, et al. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type I collagen expression[J]. J Biol Chem, 2003, 278:8083-8090. doi:  10.1074/jbc.M212927200
    [30] Takashima M, Parsons CJ, Ikejima K, et al. The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation[J]. J Gastroenterol, 2009, 44:847-855. doi:  10.1007/s00535-009-0073-3
    [31] Hao LS, Zhang XL, An JY, et al. PTEN expression is down-regulated in liver tissues of rats with hepatic fibrosis induced by biliary stenosis[J]. APMIS, 2009, 117:681-691. doi:  10.1111/j.1600-0463.2009.02515.x
    [32] Zheng L, Chen X, Guo J, et al. Differential expression of PTEN in hepatic tissue and hepatic stellate cellsduring rat liver fibrosis and its reversal[J]. Int J Mol Med, 2012, 30:1424-1430. doi:  10.3892/ijmm.2012.1151
    [33] Stiles B, Wang Y, Stahl A, et al. Liver-specific deletion of negative regulator PTEN results in fatty liver and insulin hypersensitivity[corrected] [J]. Proc Natl Acad Sci U S A, 2004, 101:2082-2087. doi:  10.1073/pnas.0308617100
    [34] Sato W, Horie Y, Kataoka E, et al. Hepatic gene expression in hepatocyte-specific PTEN deficient mice showing steatohe-patitis without ethanol challenge[J]. Hepatol Res, 2006, 34:256-265. doi:  10.1016/j.hepres.2006.01.003
    [35] McCarroll JA, Phillips PA, Kumar RK, et al. Pancreatic stellate cell migration:role of the phosphatidylinositol 3-kinase (PI3-kinase) pathway[J]. Biochem Pharmacol, 2004, 67:1215-1225. doi:  10.1016/j.bcp.2003.11.013
    [36] Covey TM, Edes K, Fitzpatrick FA. Akt activation by arachidonic acid metabolism occurs via oxidation andinactivation of PTEN tumor suppressor[J]. Oncogene, 2007, 26:5784-5792. doi:  10.1038/sj.onc.1210391
    [37] Vonlaufen A, Joshi S, Qu C, et al. Pancreatic stellate cells:Partners in crime with pancreatic cancer cells[J]. Cancer Res, 2008, 68:2085-2093. doi:  10.1158/0008-5472.CAN-07-2477
    [38] Gong H. Analysis of intercellular signal transduction in the tumor microenvironment[J]. BMC Syst Biol, 2013, 7 Suppl3:S5. doi:  10.1186/1752-0509-7-S3-S5
    [39] Ince MN, Elliott DE. Immunologic and molecular mechanisms in inflammatory bowel disease[J]. Surg Clin North Am, 2007, 87:681-696. doi:  10.1016/j.suc.2007.03.005
    [40] Sheppard K, Kinross KM, Solomon B, et al. Targeting PI3 kinase/AKT/mTOR signaling in cancer[J]. Crit Rev Oncog, 2012, 17:69-95. doi:  10.1615/CritRevOncog.v17.i1.60
    [41] Nakanishi A, Wada Y, Kitagishi Y, et al. Link between PI3K/AKT/PTEN pathway and NOX protein in diseases[J]. Aging Dis, 2014, 5:203-211. doi:  10.14336/AD.2014.0500203
    [42] Burke JP, Cunningham MF, Sweeney C, et al. N cadherin is overexpressed in Crohn's stricture fibroblasts and promotes intestinal fibroblast migration[J]. Inflamm Bowel Dis, 2011, 17:1665-1673. doi:  10.1002/ibd.21543
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  57
  • HTML全文浏览量:  17
  • PDF下载量:  2
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-02-09
  • 刊出日期:  2017-09-30

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！